A supplementary infusion of glucose-dependent insulinotropic polypeptide (GIP) with a meal does not significantly improve the β cell response or glucose tolerance in type 2 diabetes mellitus
| Date first appeared online | |
| DOI | 10.1016/0168-8227(89)90014-4 |
| Authors | Luzio S. |
| Journal Name | Diabetes Research and Clinical Practice |
| Volume | 7 |